)
Visual
test
Metropolis Healthcare
Metropolis Healthcare (METROPOLIS) investor relations material
Metropolis Healthcare Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary5 Feb, 2026
Executive summary
Group revenues grew 26% year-on-year in Q3, with nine-month revenues up 24% year-on-year, driven by balanced volume expansion, improved test mix, and successful integration of recent acquisitions.
Organic revenue growth was 15% for Q3 and 13% for the nine months, with patient volume up 9% and test volume up 8% year-on-year.
Specialty diagnostics, preventive healthcare (TruHealth), and complex testing are key growth drivers, with genomics, digital/AI initiatives, and premium offerings as strategic priorities.
Integration of CORE Diagnostics and other recent acquisitions is progressing well, with synergy benefits expected by year-end.
Board approved a 3:1 bonus share issue, reflecting strong financials and confidence in long-term growth.
Financial highlights
Q3FY26 group revenue up 26% YoY to INR 406 Cr; EBITDA up 32% YoY to INR 95 Cr; PAT (excluding exceptional) up 63% YoY to INR 51 Cr.
Organic EBITDA grew 29% year-on-year, with margins at 25% (up 280 bps); PAT (excluding exception items) grew 52% year-on-year to INR 48 crore.
Group EBITDA margin was 23.4%, lower than organic due to CORE Diagnostics' margin profile.
One-time Labor Code implementation cost of INR 9 crore at group level impacted profitability.
Company remains net debt-free with INR 127 crore in cash reserves.
Outlook and guidance
Confident of achieving 12%-13% organic revenue growth and expanded margins for FY 2026, aiming for the higher end of the range.
Q4 expected to be seasonally stronger, with improved gross margins at CORE Diagnostics and continued network expansion.
Targeting mid-teen revenue CAGR from FY23 to FY26 and aiming to regain pre-COVID margin profile.
Bonus shares to be issued within two months of board approval, pending shareholder and regulatory nods.
Medium-term volume growth aspiration remains at 7%-8% per year.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebPGIL
Double-digit revenue and profit growth, margin gains, and FTAs to further boost expansion. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026.
Next Metropolis Healthcare earnings date
Q4 25/2613 May, 2026
Metropolis Healthcare
Next Metropolis Healthcare earnings date
Q4 25/2613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Metropolis Healthcare is an India-based diagnostics company that provides pathology and laboratory testing services. The company offers a wide range of clinical laboratory tests across specialties such as biochemistry, hematology, microbiology, molecular diagnostics, and cytogenetics. It operates a network of diagnostic centers and collection facilities serving hospitals, clinics, corporate clients, and individual patients. Metropolis Healthcare also provides specialized testing services and preventive health check-up packages. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage